Bioprinting for treating arthritis and the development of tissue

Written by Kenny Dalgarno

Kenny Dalgarno (Newcastle University, UK) explains how bioprinting is being used to research arthritis treatment and how bioprinted tissue models are further being applied to research with osteoporosis and drug development.

Register as a member of 3DMedNet for exclusive 3DMedLIVE content


For the past decade, Kenny Dalgarno has been conducting research in the area of additive manufacturing, with applications in rapid prototyping and manufacturing as well as polymer engineering. Dalgarno’s research has had an increasing emphasis on applications in biomedical engineering, tissue engineering and regenerative medicine with work supported by the Engineering and Physical Sciences Research Council (EPSRC), the European Commission, Arthritis Research UK, the Carbon Trust and industrial partners. Dalgarno currently maintains the position of Sir James Woodeson Professor of Manufacturing Engineering at Newcastle University, whilst simultaneously acting as Deputy Director of the Arthritis Research UK Tissue Engineering Centre, Deputy Director of the EPSRC’s Centre for Innovative Manufacturing in Medical Devices and as a Coordinator of the FP7 RESTORATION project. Dalgarno is also the Newcastle University Lead Investigator for the EPSRC Centre for Doctoral Training in Additive Manufacture and 3D Printing.

“I think there’s a recognition that drug testing at the moment doesn’t result in many drugs actually reaching patients. It’s clear that we do need some new ways of evaluating drugs and so the 3D tissue models are a big thing at the moment in terms of that going forward.”

Dalgarno was interviewed about bioprinting for arthritis treatment research at 3DMedLIVE 2019: 3D printing in surgery. To access more exclusive interviews and content from 3DMedLIVE 2019, watch this space on 3DMedNet >>

>> Find out more about 3DMedLIVE

Interview segments:

  • Introduction [00:03]
  • Working with arthritis and 3D-printed implants [00:34]
  • Developing tissue models with bioprinting [01:27]
  • Integrating research aims and objectives [01:59]
  • Commercializing ‘reactor jet impingement’ [02:42]
  • Developing bioprinted tissue models for drug evaluation [03:19]
  • Developing biomaterials for 3D printing devices for osteoporosis [04:04]
  • Training the next generation in biofabrication [04:40]
  • Developing the field of bioprinting [05:04]
  • Bringing bioprinting to the market [05:44]


You may also be interested in:

The opinions expressed in this feature are those of the interviewee and do not necessarily reflect the views of 3DMedNet or Future Science Group.